Barclays Share Price Forecast 2024, 2025 and 2030

Jitanchandra Solanki
10 Min read

During the pandemic, Barclays’ share price collapsed to levels not seen since the financial recession. However, since then banking stocks have performed better as central banks around the world began to increase interest rates once again to stave off inflation. 

With Barclay's share price now up more than 150% from the pandemic lows, investors are now asking the question: ‘Are Barclays Shares a Good Buy?’

In this ‘Barclays Share Price Forecast' article, we explore the latest news and factors affecting Barclays' share price and what the analysts are forecasting for the stock.

Barclays Share Price Forecast: Buy, Sell or Hold?

Most UK banking stocks had been trending lower even before the pandemic hit. Government regulation, loss of income through the closure of investment banking units and slow developments to compete with fintech banks have plagued the sector for years.

However, in 2024 analysts are now forecasting a long-term period of growth for banking stocks due to the internal changes that have improved banks’ balance sheets. Investors are also bullish on the banking sector as a whole due to central banks starting to increase interest rates – an environment that has historically been good for banks as they can lend out at a higher interest rate thereby helping their margins to increase.

Analysts have also started to turn bullish on banks. While you cannot solely rely on analyst ratings to make investment decisions – as they too can get it wrong – it does provide a good backdrop to help understand the sentiment regarding a company’s fundamentals.

According to 11 analysts polled by TipRanks, there are currently 8 buy ratings on the stock, 3 hold and 0 sell. 

Source: TipRanks

The Barclays share price forecast for the next 12 months has the highest price target at GBX 320.00p, the lowest price target at GBX 180.00p, providing an average price target of GBX 242.27p. At the time of writing this presents a near 48% uplift to the average price target for Barclays share price. 

Of course, a stock never moves in a straight line forever so there will be ups and downs that develop in the share price. As always, thorough research and risk management is prudent before making any decisions. Further below, we explore some of the factors affecting Barclays' share price. 

Barclays Share Price Live

Barclays Shares Buy or Sell Research

A common question among investors is ‘Should I buy Lloyds or Barclays shares?’ Let’s have a look at the fundamentals of Barclays. 

One reason many investors favour analysing Barclays' share price rather than other UK banks is that Barclays is a global bank that has multiple revenue streams. For example, Barclays not only operates as a high street bank but also as an investment banking and commercial banking division. 

This diversification has helped Barclays massively. Recent earnings report has shown that Barclays’ profits have surged higher as the investment banking division made nearly £1 billion in deal-making fees. This is largely thanks to a lot of deal-making and mergers and acquisitions in most stock sectors over the pandemic. 

While investment banking revenues are likely to dip at some point, the bank may receive a boost from its traditional banking services due to rising interest rates. Banks tend to perform well when interest rates rise as it can lead to bigger margins and profits on consumer and business lending. Barclays is well-positioned as a UK bank to capitalise on global trends with the Bank of England and US Federal Reserve continuing to raise rates in 2023 and beyond.

However, there are some major headwinds for UK banks. In the second half of 2023, analysts have been forecasting for banks to report declining balance sheets. The deposits consumers are putting into bank accounts are now falling faster than the loans being taken out. The cost of living crisis has had an effect on banking activity as well. 

Barclays Share Price Dividend

Bank shares tend to be popular among institutional pension fund managers who seek out income from shares in the form of dividend payouts. While some stocks pay out monthly dividends, most pay them out quarterly. Currently, the dividend amount for Barclays shares is GBX 5p annually. The last ex-dividend date was 23 February 2023 and Barclays has been increasing its dividend since February 2021. 

Source: TipRanks, 21 July 2023

With a rising dividend amount since February 2021, this may attract more longer-term investors to Barclays shares. However, with Barclays' share price still down from its record high in 2007, the stock may attract more value investors than growth investors

Currently, the dividend yield for Barclays shares is 4.55% making it a top dividend stock to watch. 

Barclays Shares Investment Options

With Admirals you can buy Barclays shares from three different account types, ensuring you can structure your investment to your own needs and risk profile. These accounts include: 

1. Invest.MT5 Account. This account allows you to buy real stocks and ETFs (exchange-traded funds) from 15 of the largest stock exchanges in the world.

  • Invest in Barclays with only 0.1% commission.
  • Enjoy a low minimum transaction fee of just 1 GBP – useful for small accounts! 
  • Invest with a broker authorised and regulated by the Financial Conduct Authority (FCA), the Cyprus Securities and Exchange Commission (CySEC) and Australian Securities and Investments Commission (ASIC).

2. Trade.MT5 Account. This account allows you to speculate on the price direction of a security using Contracts for Differences (CFDs) on more than 4,000+ financial instruments covering global shares, commodities, indices and currencies.

  • Speculate on the asset, rather than own the asset. This allows to trade long and short and potentially profit from rising and falling markets.
  • Trade on margin. This means you can control a larger position with a smaller deposit. For most retail traders this means you may only 20% of the total trade size to be held as a deposit to open the trade. Trading on margin can amplify profits and losses so be careful.
  • Trade with a broker regulated all around the world and which provides you with a range of trading platforms and upgrades completely FREE! 

3. Demo Account. Did you know you can open a Trade.MT5 and Invest.MT5 demo account completely free? This means you can test out all of the features, services and potential trading ideas yourself in a virtual environment until you are ready to go live.

Open a Live Account

Trade the Live Markets and Trade Efficiently

How to Buy Barclays Shares in 4 Steps

With Admirals, you can invest in global stocks and ETFs with the following commissions:

  • UK shares – 0.1% of trade value, 1 GBP minimum commission.
  • US stocks – From $0.02 per share, 1 USD minimum commission. 

You can learn more about investing commissions on the Admirals Contract Specification page. You can search for global stocks from the Invest.MT5 web platform and invest in four steps:

  1. Open an account with Admirals.
  2. Click on Trade on one of your live or demo trading accounts to open the web platform.
  3. Search for your symbol at the top of the search window.
  4. Click Create New Order in the bottom window to open a trading ticket to input your trade size, stop loss and take profit level.
Source: Example of a chart and trading ticket from the Trade.MT5 web trading platform. Illustrative purposes only. 21 July 2023.

The World's Premier Multi Asset Platform


Why Buy Barclays Shares with Admirals?

✔️ Admirals is authorised and regulated by the UK Financial Conduct Authority (FCA) and other well-known financial regulators. 

✔️ Invest in real stocks and ETFs from around the world and build a passive income stream through dividend investing. 

✔️ Enjoy a low commission of just 0.1% on UK shares and a low minimum transaction fee of just 1 GBP.

Click on the banner below and get started today.

Invest in the world’s top instruments

Thousands of stocks and ETFs at your fingertips

FAQs on Barclays Share Price Forecast

 

Why Barclays share price falling?

While Barclays' share price has risen nearly 150% since the lows of the pandemic it has struggled recently with its share price falling. The balance sheets at banks have been falling has consumers put less money in their accounts and instead borrow more due to the cost of living crisis. This has impacted most banking stocks. However, rising interest rates may help banking stocks to recover as they can lend out at a higher rate and increase their margins.

 

Is Barclays shares a buy sell or hold?

The consensus among 11 analysts polled by TipRanks, shows 8 buy ratings from Barclays share price, 3 hold and 0 sell ratings. 

 

What is Barclays dividend forecast for 2023?

Currently, Barclays has a dividend payout of 5p per share. Analysts are forecasting this to rise to 8.6 p per share by the end of 2023, increasing to 9.7p per share in 2024 and 10.5p in 2025. Currently, the Barclays annual dividend yield is 4.55%.

 

INFORMATION ABOUT ANALYTICAL MATERIALS:

The given data provides additional information regarding all analysis, estimates, prognosis, forecasts, market reviews, weekly outlooks or other similar assessments or information (hereinafter “Analysis”) published on the websites of Admirals investment firms operating under the Admirals trademark (hereinafter “Admirals”). Before making any investment decisions please pay close attention to the following:

  • This is a marketing communication. The content is published for informative purposes only and is in no way to be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and that it is not subject to any prohibition on dealing ahead of the dissemination of investment research.
  • Any investment decision is made by each client alone whereas Admirals shall not be responsible for any loss or damage arising from any such decision, whether or not based on the content.
  • With a view to protecting the interests of our clients and the objectivity of the Analysis, Admirals has established relevant internal procedures for the prevention and management of conflicts of interest.
  • The Analysis is prepared by an independent analyst (Jitan Solanki, hereinafter “Author”) based on personal estimations.
  • Whilst every reasonable effort is taken to ensure that all sources of the content are reliable and that all information is presented, as much as possible, in an understandable, timely, precise and complete manner, Admirals does not guarantee the accuracy or completeness of any information contained within the Analysis.
  • Any kind of past or modelled performance of financial instruments indicated within the content should not be construed as an express or implied promise, guarantee or implication by Admirals for any future performance. The value of the financial instrument may both increase and decrease and the preservation of the asset value is not guaranteed.
  • Leveraged products (including contracts for difference) are speculative in nature and may result in losses or profit. Before you start trading, please ensure that you fully understand the risks involved
TOP ARTICLES
How to Invest in Coca Cola Shares And Dividends in 2023
Are Coca Cola Shares worth watching in 2023? The leading soft drinks company has been paying out dividends for decades, each time at a higher value, in addition to earning impressive returns. This makes it an attractive investment. It is one of the most well-known brands in the world,...
What Is Market Cap?
If you read articles about the stock market or the economy, you will probably have come across the term "market capitalisation" or “market cap” at some point. But what is market cap? And what can it tell you about a company?In this article, we will answer these questions in detail. Furthermore, we w...
Top 3 Best Biopharma Stocks to Watch
The pharma industry is a massive one and encompasses several segments. Among those is biopharma, which is likely set to become increasingly popular in the health sector. One of the fastest-growing segments within the pharma industry, biopharma is likely well-positioned to continue on the rise. We a...
View All